Načítá se...
A Randomized, Controlled, Phase 1 Study of the Safety and Immunogenicity of the AMA1-C1/Alhydrogel(®) + CPG 7909 Vaccine for Plasmodium falciparum Malaria, in Semi-immune Malian Adults
A double blind, randomized, controlled Phase 1 clinical trial was conducted to assess the safety and immunogenicity in malaria exposed adults of the Plasmodium falciparum blood stage vaccine candidate Apical Membrane Antigen 1- Combination 1 (AMA1-C1)/Alhydrogel(®) with and without the novel adjuvan...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2009
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2808270/ https://ncbi.nlm.nih.gov/pubmed/19874925 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2009.10.087 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|